Despite updated understandings of IOP and glaucoma risk, cutoff values are still a primary influence on treatment ...

Current foundation models outperform trainees on text questions but struggle with multimodal ophthalmic imaging ...

AI has the potential to transform cataract surgery outcomes for the better, according to a speaker. Surgical planning, predictive analytics for patient recovery and postoperative assessments are a few ...

Patient awareness of glaucoma differs markedly depending on urban and rural locations and the patient population, and that awareness or lack thereof impacts diagnosis, treatment, ...

Using neutral language with patients and thorough documentation can help mitigate your practice’s legal risks when utilizing ...

Background/aims Up-to-date, stratified estimates of the number of individuals affected by glaucoma in the UK are lacking.

Nanoscope Therapeutics has received Pioneering Regenerative Medical Product (Sakigake) and Orphan Drug designations for ...

A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic ...

Researchers have identified a metabolically sensitive cell subtype in the eye's drainage system which shows early signs of ...

Irbid, Jan. 20 (Petra) - The opening of the new Princess Basma Hospital building marks a qualitative leap for the health ...

Four firms collaborate on foaming technology that incorporates recycled content while maintaining performance in multiple ...

By Brad Sorensen, CFA NASDAQ:YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial ...